Ranked #7,118 of 8,699 institutional investors
Propel Bio Management, LLC
Los Angeles, CA
$149M
US stock portfolio at live prices · today −$2.6M (−1.71%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $181M
- Change from Q2 2026
- −$9.8M (−5.12%)
- Positions
- 30 · 5 new, 4 sold out
- Filed
- Nov 13, 2026
Holdings
Q3 2026 13F, live pricesPAGP 22.2%QUIT 15.3%DCTH 7.83%COLL 6.96%OBIO 4.23%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| PAGP Plains GP Holdings, L.P. | 1,272,360 | $32.9M | 22.2% | Unchanged |
| QUIT Achieve Life Sciences, Inc. | 3,864,148 | $22.7M | 15.3% | Reduced −4% |
| DCTH Delcath Systems, Inc. | 604,664 | $11.6M | 7.83% | Reduced −31% |
| COLL Collegium Pharmaceutical, Inc. | 410,175 | $10.3M | 6.96% | New |
| OBIO Orchestra BioMed Holdings, Inc. | 896,701 | $6.3M | 4.23% | Unchanged |
| MAZE Maze Therapeutics, Inc. | 191,998 | $6.2M | 4.19% | Added +338% |
| PHAT Phathom Pharmaceuticals, Inc. | 1,105,913 | $5.6M | 3.78% | Added +5% |
| CORT Corcept Therapeutics Incorporated | 75,274 | $4.9M | 3.29% | Reduced −45% |
| CMPS COMPASS Pathways plc | 549,186 | $4.8M | 3.20% | Reduced −4% |
| IVA Inventiva S.A. | 1,133,954 | $3.9M | 2.63% | Reduced −11% |
| MIST Milestone Pharmaceuticals Inc. | 9,449,727 | $3.8M | 2.54% | Added +27% |
| SABS SAB Biotherapeutics, Inc. | 1,187,422 | $3.5M | 2.33% | Added +10% |
| KYTX Kyverna Therapeutics, Inc. | 700,595 | $3.1M | 2.06% | Reduced −21% |
| ARTV Artiva Biotherapeutics, Inc. | 696,436 | $2.7M | 1.80% | Unchanged |
| CRVS Corvus Pharmaceuticals, Inc. | 264,310 | $2.6M | 1.78% | Added +276% |
| OVID Ovid Therapeutics Inc. | 1,018,721 | $2.4M | 1.61% | Reduced −9% |
| ABEO Abeona Therapeutics Inc. | 956,007 | $2.3M | 1.58% | Reduced −3% |
| PROK ProKidney Corp. | 2,009,733 | $2.1M | 1.43% | New |
| OCUL Ocular Therapeutix, Inc. | 357,966 | $2.1M | 1.41% | Unchanged |
| CABA Cabaletta Bio, Inc. | 2,049,471 | $2.1M | 1.39% | New |
| PALI Palisade Bio, Inc. | 2,224,189 | $2.1M | 1.39% | Reduced −14% |
| FDMT 4D Molecular Therapeutics, Inc. | 179,154 | $1.9M | 1.29% | Reduced −29% |
| IMUX Immunic, Inc. | 236,734 | $1.7M | 1.18% | Reduced −27% |
| SCYX SCYNEXIS, Inc. | 541,474 | $1.4M | 0.95% | Reduced −0% |
| SGP SpyGlass Pharma, Inc. | 41,418 | $1.3M | 0.86% | New |
| IRD Opus Genetics, Inc. | 270,036 | $1.1M | 0.74% | New |
| CLDX Celldex Therapeutics, Inc. | 37,539 | $1.0M | 0.71% | Reduced −64% |
| AQST Aquestive Therapeutics, Inc. | 278,723 | $1.0M | 0.70% | Reduced −81% |
| UPB Upstream Bio, Inc. | 335,389 | $671K | 0.45% | Reduced −4% |
| LONA LeonaBio, Inc. | 149,279 | $367K | 0.25% | Unchanged |